|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 272, Issue 1 302-R310, Copyright © 1997 by American Physiological Society
ARTICLES |
V. C. Chitravanshi and H. N. Sapru
Section of Neurological Surgery, New Jersey Medical School, Newark 07103, USA.
An in vivo model was used to identify the transmitter/receptor mechanisms in the phrenic nucleus that mediate carotid chemoreceptor responses. Adult male Wistar rats, anesthetized with urethan, were fixed in a stereotaxic instrument, and the blood pressure and heart rate were monitored. The rats were immobilized and artificially ventilated to maintain the end-tidal CO2 at 4.5-5%. The vagus nerves were bilaterally sectioned, and a pneumothorax was produced. Activity was recorded from one of the phrenic nerves. The spinal cord was exposed from C1 to T1 vertebral level. The dorsal and ventral rootlets of spinal nerves C3, C5, and C6, ipsilateral to the phrenic nerve from which electrical activity was recorded, were sectioned; the dorsal and ventral roots of spinal nerve C4 were left intact. Thus the phrenic nerve bursts recorded in this preparation represented output from a portion of the phrenic nucleus located in the ipsilateral C4 spinal segment. Carotid chemoreceptor stimulation by N2 inhalation increased the amplitude as well as the frequency of phrenic nerve bursts. Microinjections (50 nl) of a specific N-methyl-d-aspartic acid (NMDA) receptor antagonist (D(-)-2-amino-7-phosphonoheptanoic acid, AP-7, 50-100 mM) into the phrenic nucleus decreased the N2-induced increase in amplitude, but not the frequency, of phrenic nerve bursts. Likewise microinjections of a specific non-NMDA receptor antagonist (1,2,3,4-tetrahydro-6-nitro-2,3-dioxobenzoquinoxaline-7-sulfonamid e, NBQX, 0.5-1 mM) into the phrenic nucleus decreased the N2-induced increase in phrenic nerve burst amplitude. When AP-7 and NBQX were microinjected into the phrenic nucleus sequentially within an interval of 5 min, a drastic reduction in the N2-induced increase in phrenic nerve burst amplitude was observed. These observations suggest that both NMDA and non-NMDA receptors located in the phrenic nucleus are involved in the mediation of phrenic nerve responses to the carotid chemoreceptor stimulation.
This article has been cited by other articles:
![]() |
J. M. Bissonnette Mechanisms regulating hypoxic respiratory depression during fetal and postnatal life Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1391 - R1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Soltis, J. C. Cook, A. E. Gregg, J. M. Stratton, and K. A. Flickinger EAA receptors in the dorsomedial hypothalamic area mediate the cardiovascular response to activation of the amygdala Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R624 - R631. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Ohtake, J. E. Torres, Y. M. Gozal, G. R. Graff, and D. Gozal NMDA receptors mediate peripheral chemoreceptor afferent input in the conscious rat J Appl Physiol, March 1, 1998; 84(3): 853 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gozal, G. R. Graff, J. E. Torres, S. G. Khicha, G. S. Nayak, N. Simakajornboon, and E. Gozal Cardiorespiratory responses to systemic administration of a protein kinase C inhibitor in conscious rats J Appl Physiol, February 1, 1998; 84(2): 641 - 648. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |